Lannett Company, Inc. (NYSE:LCI)

CAPS Rating: 2 out of 5

The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.

Recs

1
Player Avatar MMCapitalMgmt (99.84) Submitted: 1/18/2007 3:00:36 AM : Outperform Start Price: $6.60 LCI Score: -27.86

Company has great financials and shows undervaluation. Additionally, generic pharmaceuticals are becoming a bigger and bigger trend.

Featured Broker Partners


Advertisement